J Voglová

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 587 citations · Full text

Hematological Malignancy, Medicine, Chronic Myeloid Leukaemia +10

Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia — distinct subgroups or two stages of the same disease?

J Voglová, L Chrobák, R Neuwírtová et al. · Leukemia Research · 2001 · 57 citations

Hematological Malignancy, Medicine, Hematology +6

Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile

Anna Kreutzman, Peter Rohoň, Edgar Faber et al. · PLoS ONE · 2011 · 47 citations · Full text

Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry

Cornelia Zeidler, Ulrike Grote, Alexander Nickel et al. · Haematologica · 2014 · 43 citations · Full text

Family Medicine, Idiopathic Neutropenia, Reproductive Health +16

Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA Registry

Edgar Faber, Vladimír Koza, Eva Demečková et al. · European Journal Of Haematology · 2011 · 33 citations